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Nanofibrous scaffolds are artificial extracellular matrices which provide natural environment for tissue formation. In
comparison to other forms of scaffolds, the nanofibrous scaffolds promote cell adhesion, proliferation and differentiation
more efficiently due to having high surface to volume ratio. Although scaffolds for tissue engineering have been
fabricated by various techniques but electrospun nanofibrous scaffolds have shown great potential in the fields of
tissue engineering and regeneration. This review highlights the applications and importance of electrospun
nanofibrous scaffolds in various fields of biomedical applications ranging from drug delivery to wound healing.
Attempts have also been made to highlights the advantages and disadvantages of nanofirbous scaffolds fabricated for
biomedical applications using technique of electrospinning. The role of various factors controlling drug distribution in
electrospun nanofibrous scaffolds is also discussed to increase the therapeutic efficiency of nanofibrous scaffolds in
wound healing and drug delivery applications.
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Nanofibers have played significant role in various fields of
biomedical research ranging from drug delivery to wound
healing due to having high surface area and opportunities
to tune their properties by varying composition and
fabrication parameters [1,2]. The fabrication of electro-
spun nanofibers using hydrophilic polymers found to
be effective in developing fast dissolving delivery sys-
tems having reduced drug–drug interactions [3-5]. The
nanofibrous scaffolds fabricated with natural and syn-
thetic polymers found to be promising for developing
drug delivery systems by electrospinning of blended
polymers or through coaxial spinning of two different
polymers along with drugs and active agents [6,7]. The
technique of electrospinning has produced nanofibrous
scaffolds that not only reduced the bulk release of en-
capsulated drugs but also found useful in developing
dual degree delivery systems for post operative surgical
treatment of the patients [8]. Recently a variety of tech-
niques has been evolved to fabricate nanofibrous scaffolds
for biomedical applications such as techniques of phase
separation [9], self-assembly [10], melt-blowing [11],
and templating system [12]. However, the technique of* Correspondence: kcgptfcy@iitr.ac.in; ikkang@knu.ac.kr
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unless otherwise stated.electrospinning found to be useful to produce nanofibrous
scaffolds [2,13,14] for various biomedical applications.
Although nanofibrous scaffolds are potentially useful
in various fields but this review focuses on applications
of electrospun nanofibrous scaffolds for biomedical ap-
plications such as drug delivery [15-17], wound healing
[18-25], and delivery of bioactive molecules [26] in tissue
engineering.Review
This review provides briefly the state of art of elctros-
pinning for nanofibrous scaffolds and highlights the recent
developments in applications of nanofibrous scaffolds in
various fields of biomedical research.Nanofibrous scaffolds by electrospinning technique
The electrospinning has been known since 1897 based
on the principle of Rayleigh [27]. Electrospinning process
utilizes the electrostatic forces to draw the fibers from the
droplet formed at the tip of spinneret. The applications of
electrospinning technique have been explored in various
fields [16,19,22,26] and several studies have been conducted
to analyze the controlling parameters of electrospinning
process [28-38].
In principle, the electrospinning needs three basic
components such as, a high voltage DC supply, grounded
collector, and syringe pump (Figure 1). On application oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Power supply
Figure 1 An electrospinning setup showing the arrangement for syringe, precursor solution, needle, liquid jet, collector, and
power supply.
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cone [36] is formed by the balance of electrical force and
surface tension of the solution. After Taylor cone forma-
tion, a charged fiber jet is produced, which moves toward
grounded collector when applied potential overcomes the
surface tension of the solution in Taylor cone. The forma-
tion of nanofibers is influenced by various parameters,
which are mainly grouped in following three categories
(A, B, and C);
A: Solution parameters, which include conductivity,
surface tension, and viscosity of solution.
B: Process parameters, which include applied voltage,
distance between tip to collector, flow rate, and
electric field induced by the collector.
C: Ambient parameters, which include temperature
and humidity.
The electrospinning technique is capable of producing
continuous fibers using wide range of material such as
polymers and their composites with ceramics. It is an
effective means to produce non-woven membranes of
nanofibers ranging from micron to nanosized diameter
[38-42]. The electrospun nanofibers possess high surface
to volume ratio, which is responsible for their importance
in various applications such as tissue engineering [43-46],
drug delivery [47-49], and other bio [50], energy related
applications [51-57]. The effect of different surfactants on
diameter of poly(lactic acid) (PLA) electrospun fibers has
been studied by Zeng et al. [58] and addition of triethylben-
zyl ammonium chloride (TEBAC) has significantly reduced
the diameter of electrospun nanofibers due to increased
conductivity and polarizibility of solution in comparison to
solution without surfactant. The addition of non ionic
surfactant such as poly(propylene oxide-ethylene oxide)
ether (PPO-PEO) (AEO10) has produced uniform fibers,
whereas, addition of anionic surfactants such as sodium
dodecyl sulfate (SDS) has shown manifold increase indiameter of electrospun nanofibers than electrospun
nanofibers produced in presence of cationic and non-ionic
surfactants. These investigations have clearly indicated that
properties of electrospun nanofibers could be controlled
using different additives and solvents.
Electrospun nanofiberous scaffolds in biomedical
applications
Over the last 30 years extensive work has been carried
for developing electrospun nanofibrous scaffolds for the
promotion of bone tissue formation and to assist in
wound healing [18-20]. Recent advancements have led
to the development of composite scaffolds, consisting
of materials that help in tissue engineering and delivery
of drugs [18-21], and growth factors [26]. To control
the release profile of encapsulated drugs, various tech-
niques have been applied using polymers of optimal
degradation and erosion. The electrospun nanofibrous
scaffolds have shown significant control on drug release
kinetics and great potential in maintaining therapeutic
doses for longer period in comparison to other drug re-
leasing scaffolds.
Electrospun nanofibrous scaffolds in drug delivery systems
The electrospun nanofibrous scaffolds found to be useful
in drug delivery systems [59] due to high surface to
volume ratio and high pore connectivity [60]. The poly-
mer based electrospun nanofibrous scaffolds are able to
provide useful way out to develop drug delivery systems
for a number of recently-developed water insoluble drugs.
The electrospun nanofiber technique is also found to be
helpful in providing a novel approach for dissolving and
releasing of even very poorly soluble drugs. The poly(vinyl
pyrrolidone) (PVP) based electrospun fibers found to be
potentially useful in improving the solubility of poorly
water soluble drugs as PVP based nanofibers are able to
provide better dispersal for poorly water soluble drugs
[61]. The electrospun nanofibrous scaffolds based drug
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providing better control on drug dosages in comparison
to other methods of drug delivery systems [62]. The
itraconazole is widely used for the treatment of Tinea
Pedis and other fungal infections; hence electrospun
nanofibrous scaffolds based drug delivery systems have
been developed and analyzed for drug release kinetics
[63]. The itraconazole release from electrospun nanofi-
brous scaffolds has shown linear dependence to the
square root of release time, which clearly indicated that
itraconazole has followed a Fickian release kinetics. The
mefoxin loaded poly(D, L-lactic acid) (PDLLA) electro-
spun nanofibrous scaffolds have shown complete release
of mefoxin within 24 h with a bulk release within initial
3 h due to aggregation of large number of mefoxin mol-
ecules at the surface of nanofibrous scaffolds [63]. These
investigations have clearly suggested that surface depos-
ition and drug aggregation has significant influence on
drug release behavior of electrospun nanofibrous scaf-
folds. The electrospun nanofibrous scaffolds from poly
(ethylene-co-vinyl acetate) (PEVA) and PLA blends con-
taining tetracycline hydrochloride have been used suc-
cessfully for the treatment of periodontal diseases in
comparison to other scaffolds [24]. The PEVA based elec-
trospun nanofibrous scaffolds have shown high release
rate than 1:1 ratios of PLA/PEVA or nanofibrous scaffolds
obtained from pure PLA. The PEVA based electrospun
nanofibrous scaffolds have released 65% of loaded
tetracycline hydrochloride within 120 h [64,65]. The
composition, morphology and structures of electrospun
nanofibers for drug delivery systems have been controlled
easily using emulsion electrospinning techniques [66,67].
The electrospun nanofibrous scaffolds have also been used
successfully in controlled delivery of genes [68], proteins
[69-71], and enzymes [72]. The scaffolds having electro-
spun nanofibers with low diameters was found to be more
effective in dual drug delivery [15-17], and applications in
post-surgical treatment of Glioma cells [73]. The elec-
trospun nanofibers for drug delivery systems are gener-
ally produced either by blend electrospinning [60], or
by coaxial electrospinning methods [6,7,68,74]. In blend
electrospinning technique, the drug is mixed with polymer
solution prior to electrospinning process, whereas in
coaxial electrospun technique [6,7], the nanofibers are
produced with core-sheath structures having drug distri-
bution in the core of the fibers [66,67]. The electrospun
nanofibrous scaffolds have been fabricated successfully by
blending drugs in polymer solution before electrospinning
fibers. Lu et al. [75] have prepared successfully, the elec-
trospun nanofibers for sustained release of plasmid DNA
using synthetic biodegradable polymers, such as PLA,
poly(glycolic acid) (PGA), and amphiphilic block copol-
ymers of PLA and poly(ethylene glycol) (PEG). Since
plasmid DNA was not compatible with studied polymersystems; hence plasmid DNA was localized more at the
surface of nanofibers and shown enhanced bulk release of
plasmid DNA from electrospun nanofibrous scaffolds.
The coaxial electrospinning technique is found to be
more useful in loading of various drugs [6,7], and bio-
active agents in polymers [76], which are forced through
a coaxial capillary channel for electrospinning in pres-
ence of applied potential. Investigations have indicated
that the coaxial technique of drug delivery systems is
particularly useful to protect the drugs, which are easily
denatured or decomposed during electrospinning of
nanofibrous scaffolds. Therefore, coaxial electrospin-
ning technique has been used successfully in fabrica-
tion of nanofibrous scaffolds loaded with liposomes
without decomposition and denaturization [77]. The
loading and drug release in electrospun nanofibrous scaf-
folds was found to be dependent on molecular weight of
the drugs, and drug release behavior has varied with the
increase in molecular weight of loaded drugs in poly(vinyl
alcohol) (PVA) based electrospun nanofibrous scaffolds
[78]. The bulk release problem of electrospun nanofi-
bers has been controlled using cross-linkers, which
controlled the diffusivity of encapsulated drugs from
the nanofibrous scaffolds. The gelatin cross-linked poly
(lactic acid-co-glycolic acid) (PLGA) nanofibers based
scaffolds have shown significant reduction in the bulk
release of encapsulated fenbufen [79,80], and similar trends
are found with PVA cross-linked electrospun nanofibrous
scaffolds [72]. Although in the beginning, it was thought
that electrospinning causes the denature of loaded drug,
subsequent studies have clearly demonstrated that the
condition of electrospinning could be carefully tuned to
maintain the chemical integrity of loaded drug [78]. The
PLGA based electrospun nanofibrous scaffolds have been
used successfully in sustained release of anti-cancer drug
for in vitro treatment of C6 Glioma cells [79]. The differ-
ential scanning calorimetric (DSC) studies have indicated
that loaded drugs are able to form solid solution in the
polymers by reducing drug-drug interactions [3-5]. The
electrospun nanofibrous scaffolds have shown a sustained
release of paclitaxel for more than 60 days comparable
to commercially paclitaxel formulation-Taxol [79]. The
water soluble polymers have been used successfully in
the fabrication of electrospun nanofibrous scaffolds for
the delivery of water insoluble drugs, such as intraconazole,
which found to be dispersed homogeneously in amorphous
polymers [62]. Zeng et al. [58] have used PLLA containing
rifamin and paclitaxel to produce uniform ultrafine
nanofibrous scaffolds for the treatment of tuberculosis
and cancer. The analysis of nanofibers by optical and
electron microscopy has precluded the formation of
rifamin crystals at the surface of nanofibers and drug
release found to be constant in presence of enzyme. In
these investigations, the bulk release was absent, which
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loaded drug in the nanofibers, and drug release has mainly
taken placed through enzymatic degradation of PLLA and
insignificant drug release has taken place through dif-
fusion or solvent penetration in the nanofibers. Since
rifamin and paclitaxel are the lipophilic drugs; hence
they were solubilized easily in PLLA but doxorubdin
hydrochloride found to be on the surface of the nanofibers
as it was not soluble in the nanofibers, which clearly indi-
cated that the solubility of drugs has played a significant
role in drug distribution and release profile from the elec-
trospun nanofibrous scaffolds. The technique of coaxial
electrospinning has been used for the delivery of plasmid
DNA and non-viral gene system, and the monitoring of
gene delivery vector for about 60 days found to be consis-
tant [68]. The properties of gene delivery vector have been
controlled by using different amount of vector and core
polymers of different molecular weights. The core-sheath
electrospun nanofibrous scaffolds have shown great po-
tential in the delivery of bovine serum protein from poly
(ε-caprolactam) (PCL) based nanofibrous scaffolds. The
protein was distributed homogeneously in the cores of the
fibers; hence nanofibrous scaffolds have shown better
release of loaded protein [68]. The water in oil emulsion
has been used to fabricate coaxial electrospun nanofibers.
The aqueous phase was having poly(ethylene oxide)
(PEO) and chloroform was containing amphiphilic poly
(ethylene oxide)-poly(L-lactic acid) diblock copolymer
[80]. The coaxial electrospun nanofibers for the delivery
of protein containing PEO in the core has protected
75% of initial activity of the protein [69]. The coaxial
electrospun nanofibers have shown better control on the
bulk release of core encapsulated growth factor, which is
reduced to 17.4% in comparison to blended nanofibers,
which shown a bulk release of 43.8% within initial
period of 6 h [72]. Further control in initial bulk release
of drugs from electrospun PCL nanofibers is made using
0–50 wt% of poly(glycerol monostearate-co-ε-caprolac-
tone) (PGC-C18) hydrophobic agent, which has reduced
initial burst release and prolonged the sustain release of
encapsulated model bioactive agent SN-38 (7-ethyl-10-
hydroxycampthothecin) [81]. The addition of PGC-C18
hydrophobic agent in PCL electrospun nanofibers has
shown a maximum bulk release of 10% of campthothecin-
11 (CPT-11) within a period of 9 weeks but without PGC-
C18 hydrophobic agent, the initial bulk release was 60%
within a few days [82]. The hydrophobicity of electrospun
nanofibers has been controlled by the entrapment of air,
which prevented the penetration of water and hydrolysis
of polymer; hence nanofibers were able to show reduced
initial bulk release and prolonged sustained release of
loaded drugs. However, air trapped electrospun nanofibers
have shown a poor distribution of the drugs. To overcome
the problem of drug interactions and drug release fromthe electrospun nanofibers loaded with dual or multiple
drugs, the fabrication of particle/polymer electrospun
composites in the drug delivery system is becoming a
topic of current interest [80,83-85]. In this technique,
the nanoparticles prepared separately have been used
in emulsion electrospining [81-84]. To prevent the in-
teractions with hydrophobic rhodamine-B (RHB) and
hydrophilic fluorescein (FLU) in PLGA electrospun fibers,
the mesoporous silica nanoparticles have been loaded to-
gether with a solution containing PLGA and drugs before
electrospinning. The particles were distributed homoge-
neously and were successful in preventing the interactions
between RHB and FLU [81]. To prevent the fast release
of FLU from nanofibers, the RHB and FLU were loaded
separately on mesoporous silica particles before mixing
with PLGA solution and electrospinning the nanofibers.
This strategy has reduced the released rate of FLU from
the nanofibers, and has shown prolonged release of FLU
[82]. The cellulose acetate phthalate (CAP) based elec-
trospun nanofibers containing antiviral drugs have been
electrospun successfully to inhibit HIV infection from man
to women during sexual intercourse without impeding the
proliferation of vaginal microflora [86]. Currently the colon
drug delivery system has attracted the attention of people
both in pharmaceutical industry and academia to develop a
delivery system for the treatment of diseases associated
with colon such as colon cancer, ulcerative colitis and
diarrhea. Colon is a suitable site for the delivery of poorly
adsorbed drugs due to its long retention time. The nanofi-
bers based colon delivery systems was found to be useful
substitutes for large delivery systems and electrospun
nanofibers loaded with mixture of ERS and ES in ethanol
have been fabricated containing colon specific indometh-
acin [87]. To ascertain the homogeneous distribution of
indomethacin in the nanofibers, the nanofibers were
analyzed by differential scanning calorimetry [3-6]. The
absence of drug-polymer interactions has been supported
by FT-IR analysis. The nanofibers were electrospun using
appropriate polymer-drug ratios and optimizing the
viscosity of polymer solution and type of solvents. The
drug release profile of diclofenac sodium from electrospun
nanofibers found to be pH dependent and exhibited better
drug release in colon than that of a physical mixture of
diclofenac sodium and Eudragit L 100–55 polymer [88].
Although electrospun nanofibers are excellent drug
carriers but there are still some issues that need to be
addressed. One challenge is to control the bulk release
of drugs that arises due to surface adsorption and ag-
gregation of drugs at the surface of electrospun fibers
[89], especially when drug loading is higher. However,
coaxial and emulsion methods of electrospinning have
produced nanofibers with significant reduction in initial
bulk release [90,91]. Other challenges are to retain the
bioactivity or functional efficiency of loaded drugs in the
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during blending of drugs in the polymer solution [92].
The distribution of loaded drugs has also shown signifi-
cant influence on their activities in the nanofibers such as
surface deposition of DNA in chitosan nanofibers has
shown different activity then its homogeneous distribution
in the fibers [93].
Electrospun nanofibrous scaffolds in wound healings
The polymer-based of electrospun nanofibrous scaffolds
play significant role in wound healings; hence, selection
of appropriate polymer is very important to obtain nano-
fibrous scaffolds that would match the required proper-
ties of wound healing materials. Polysaccharides such as
chitosan, cellulose, and hyaluronic acid (HA) as well as
proteins, such as collagen and silk have been electrospun
for localized drug delivery applications [94]. Many of these
polymers have specific properties that promote wound
healing. For instance, chitosan exhibits both antibacterial
and hemostatic activities. The HA has been used as bio-
material in various fields of biomedical research such as,
dermal filler scaffolds for tissue engineering and drug
delivery devices [95]. The physical and biological activities
of 1,4-butanedioldiglycidyl ether cross-linked HA has
been evaluated recently, which clearly indicated that
HA particles were having excellent biocompatibility;
hence might be useful in fabrication of wound healing
nanofibrous scaffolds. Similarly recent studies on carboxy-
methyl cellulose (CMC) hydrogels have indicated that
CMC gels could be used in drug delivery systems and
wound healing applications [96]. Synthetic polymers
which are commonly used for wound healing applications
include PEO [97-99], PLA [75,100-103], PCL [104], and
PVA [105]. Electrospun nanofibrous scaffolds of these
polymers have displayed high mechanical strength in
comparison to natural polymers. Additionally, synthetic
polymers were found to be soluble in a wider range of
solvents, which facilitated their electrospinning process
[106]. Often wound healing scaffolds from biopolymers
are electrospun in conjunction with a synthetic polymer
in order to fine-tune the mechanical, degradation, and/or
morphological features of the porous membranes to ac-
complish the needs of individual patient. To accelerate the
wound healings and to reduce the postsurgical infections,
the release of two or more different drugs at proper time
and appropriate doses, has been achieved with the help
of electrospun fibers [107,108]. After surgical operations,
usually the infection and pain occurs frequently; hence,
sustained release of antibiotics and analgesics from elec-
trospun fibers has been found useful to overcome the
post-surgical complications. The PLLA, poly(orthoester)
(POE), and PLGA [108] nanofibers loaded with drugs
have been used in sustained and controlled release ap-
plications. The implants used in wound dressings musthave optimal mechanical strength to support the healing
process [109]. The poly(ethylene-co-vinyl alcohol) (EVOH)
electrospun nanofibrous scaffolds loaded with Ag nanopar-
ticles have been used as dressing material in skin wound
healings to prevent the inflammation by controlled release
of Ag nanoparticles [110]. The nanofibers based dressing
materials have shown better clinical properties in skin
wound treatment as compared to existing woven and non-
woven materials. The anti-bacterial properties of electro-
spun nanofibers have been evaluated with staphylococcus
aureus, which is one of the main pathogenic bacteria
found on the surfaces of skin burns. To assess the
pathogen-restraining ability of Ag encapsulating naofibers
four samples with different amount of Ag nanoparticles
were prepared ranging from 0.03-0.15 g in 10 mL 80:20
mixture of 2-propanol and water. A linearly increasing
effectiveness is found with highest Ag concentration yield-
ing in the biggest loop for the same area of the fiber
patches, clearly indicated a stronger pathogen-restraining
effect but no bacteriostatic loop was observed for pure
EVOH fibers without Ag.
Electrospun nanofibrous scaffolds in delivery of biogenic
molecules
The development of tissue-engineered organs requires
the maintenance of cell viability and differentiated func-
tion, encouragement of cell adhesion, cell proliferation,
and modulation of direction and speed of the cell migra-
tion. The cell activities are controlled by the delivery of
various growth factors such as, transforming growth
factor-β1 (TGF-β1) to induce osteogenesis and chondro-
genesis from bone marrow–derived mesenchymal stem
cells. Also, brain derived neurotrophic factor (BDNF) is
able to enhance regeneration of spinal cord injury. The
presence of hydroxybutylate or β-mercaptoethanol can
help the differentiation of bone marrow-derived mesechy-
mal stem cells to neuronal cells. The release of these bio-
molecules from electrospun nanofibrous scaffolds is useful
to control and regeneration of diseased organs. The easiest
method for the delivery of bioactive molecules is the injec-
tion near the site of proliferating and differentiating cells,
but direct injection of biomolecules is difficult due to their
short life time, high molecular weight and size of the
growth factors. The growth factors are soluble signaling
proteins capable of instructing specific cellular responses
for cell proliferation, migration and differentiation [111].
However, due to short biological stability, the direct deliv-
ery to the site is difficult. The fabrication of nanofibrous
scaffolds loaded with growth factors is found to be an
useful strategy for control release of growth factors in
biological systems. The growth factors have low tissue
penetration and their toxicity is another problem, which
needs to be considered during their applications [112].
Therefore, locally controlled release of bioactive molecules
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control the structures and release profile of bioactive mol-
ecules. The activity of bioactive molecules depends on the
type of material and methods of their conjugation with
scaffolds. The tethering of insulin and transferring on the
surface of poly(methyl methacrylate) has shown different
activity in the growth of fibroblast as compared to dis-
persed or physically adsorbed molecules of the protein
[113]. Electrospun nanofibers have been found useful in
site specific delivery of various biogenic molecules and for
the treatment of various infections and cancers. The
loaded biogenic molecules are released in therapeutic
dosage from the electrospun nanofibrous scaffolds. The
inherent high porosity of electrospun nanofibers is
responsible for their precise degradation and release of
loaded drugs. PLGA and PLA–PEG block copolymer-
based nanofibrous scaffolds have been used successfully
for the delivery of plasmid [114]. The delivery of biogenic
molecules can be controlled by tuning the composition of
fibers and their morphology. The angiogenic factors, such
as androgen play critical roles in proliferation and migra-
tion of keratinocytes, fibroblasts, and endothelial cells
to promote angiogenesis and wound healings [115].
The delivery of growth factors by electrospun nanofibers
remains a challenge as the growth factors could lose their
bioactivity during the harsh process of nanofiber formation
[116]. The collagen-PCL electrospun nanofibers loaded
with synthetic anti-androgen receptor [5-hydroxy-1,7-bis
(3,4-dimethoxyphenyl)-1, 4, 6-heptatrien-3-one] have been
fabricated and evaluated for their activity [117]. The
bioactive molecules loaded nanofibers have facilitated,
cells migration, cells growth, and differentiation in wound
healing and skin regeneration.
Electrospun nanofibrous scaffolds in delivery of catalysts
The polystyrene electrospun nanofibrous scaffolds have
been used for the delivery of α-chymotripsin and cata-
lytic activity in biotransformation [118]. The nanofibrous
delivery of α-chymotripsin has shown enhanced hydrolytic
activity (65%) in comparison to direct applications. The
PVA electrospun nanofibers have been used to study
the releases kinetics of protein and its bioactivity inFigure 2 SEM micrographs of electrospun nanofibrous scaffolds using
(c) 70/30 (adapted from reference [127]).physiological conditions [119]. The nanofibrous scaffolds
were able to release protein in a controlled and sustained
manner without altering the bioactivity of released
protein.
Electrospun nanofibrous scaffolds in tissue engineering
Amongst the various types of scaffolds, the electrospun
nanofibrous scaffolds have attracted great attention in
tissue engineering due to high surface to volume ratio
and due to various possibilities to control their proper-
ties and applications [120-123]. The electrospun nanofi-
brous scaffolds are cost effective and able to act as extra
cellular material to provide cell adhesion, proliferation
and differentiation. The electrospun nanofibers for bone
tissue culturing and regeneration utilize a range of
biopolymers with synthetic origin, which include poly
(α-hydroxyl acid) and poly(hydroxyalkanoate), such as
poly(hydroxybutyrate) (PHB). The natural polymers such
as collagen, gelatin, silk, and chitosan are also considered
useful for bone tissue regeneration. The PCL has long
been studied as a degradable nanofiber matrix for bone re-
generation [124] and Rat bone marrow has demonstrated
the secretion of type I collagen and calcium mineralization
within 4 weeks of culturing. The PLA nanofibers have also
shown good response toward MC3T3-E1 bone cells [125].
The PHB and poly(hydroxybutyrate-co-hydroxyvalerate)
(PHBV) electrospun nanofibers have shown enhanced
osteoblastic activity equivalent to flat membrane scaffolds
[126]. The gelatin has been used as a tissue engineering
material by blending with PHBV, due to its low cost and
hydrophilicity. The PHBV/gelatin nanofibrous scaffolds
were obtained by co-electrospinning a transparent poly-
mer solution of gelatin and PHBV in 2,2,2-trifluoroetha-
nol (TFE) at a volume ratio of 50/50 [127]. The effect of
gelatin on the morphology of nanofibrous scaffolds was
examined using different ratios of PHBV and gelatin
(Figure 2).
A smooth and uniform electrospun nanofibrous scaf-
folds were obtained by varying the weight percent from
2-8% in the solvent (Figure 3).
The PHBV and collagen (Col) nanocomposite in
1,1,1,3,3,3-hexafluoro-2-isopropanol (HFIP) has alsoa PHBV/gelatin solution at TFE 6 wt%; (a) 30/70, (b) 50/50, and
Figure 3 SEM micrographs of electrospun nanofibrous scaffolds using TFE solutions with different amount of PHBV/gelatin (50/50);
(a) 2 wt%, (b) 4 wt%, (c) 6 wt%, and (d) 8 wt% (adapted from reference [127]).
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for tissue engineering [128] at different weight ratios of
PHBV and collagen and using spinning parameters as
shown in Table 1.
On acceleration of solution jet toward grounded collector,
the solvent evaporated and a charged polymer nanofiber
was deposited on grounded collector as nanofiber web.
The electrospinning of nanofibrous scaffolds was done at
different weight ratios of PHBV and collagen (7:3, 5:5, and
3:7), which produced nanofibrous scaffolds with smooth
morphology. The addition of PHBV in collagen has pro-
duced nanofibrous scaffolds with heterogeneous surfaces,
which enhanced the application of electrospun nanofibers
in tissue engineering (Figure 4). The synthetic polymers
after blending with natural polymers have been used
successfully in tissue engineering. The electrospun nanofi-










PHBV 2 7 15 1.5
PHBV-Col 2 12 22 1.0
Collagen 2 20 15 1.5
*Distance is from the spinneret to grounded collector (adapted from
reference [128]).PCL and PLA have shown better proliferation and ex-
pression for osteoblastic cells in comparison to pure
PCL and PLA [129,130]. The blending of collagen with
PCL has proved to be useful in improving the mechan-
ical properties of electrospun fibers as percent elong-
ation has increased significantly on addition of collagen
in PCL without altering the tensile strength of original
PCL [131].
The electrospun nanofibrous scaffolds fabricated from
PEO blended silk and loaded with BMP-2 have shown
higher osteogenic differentiation and calcification as
compared to nanofibrous scaffolds obtained without
BMP–2 [132].
Electrospun nanofibrous scaffolds in vascular graft
applications
The electrospinning technique has also been found useful
in fabrication of nanofibrous scaffolds for cardiovascular
tissue engineering and small-caliber vascular grafts using
solution of PLA or PCL in methylene chloride. The so-
lution of PLA or PCL in methylene chloride was loaded
into 1 mL syringe containing blunt 18 gauge needle at a
voltage ranging from 10–15 kV and circular cylindrical
counter electrode was used to produce tube like struc-
tures. A tube like vascular graft has been also been devel-
oped using solution of PLA and water soluble elastin in
presence of triethylamine [133]. These investigations have
ab
Figure 4 AFM phase images of nanofibrous scaffold surface; (a) PHBV and (b) PHBV–Col (Adapted from reference [128]).
Gupta et al. Biomaterials Research 2014, 18:5 Page 8 of 11
http://www.biomaterialsres.com/content/18/1/5clearly indicated that electrospinning could also be used
in fabrication of vascular grafts and scaffolds for biomed-
ical applications.
Conclusions
The various studies reported on applications of nanofibrous
scaffolds have clearly indicated that the technique of elec-
trospinning is of great significance and useful in fabrication
of nanofibrous scaffolds for biomedical applications using
biodegradable synthetic and natural polymers. Though
the technique of electrospinning is quite old but it is
able to produce micro to nanometer sized fibers for tissue
engineering, delivery of regenerative medicines and wound
healing applications. The onsite delivery of catalysts and
bioactive molecules could be achieved with the help of
electrospun nanofibers without any loss in their activities
and structures. The electrospinning is emerging as an
interdisciplinary area of research and possess tremendous
scope for its improvements by using suitable biomaterials
and controlling fabrication parameters. The techniques of
coaxial and emulsion electrospinning are the areas of
current interest and could be used in fabrication of drug
loaded nanofibers for biomedical applications. Tissueengineering is an interdisciplinary approach for tissue
regeneration through integration of specific cells with
electrospun nanofibers. Similarly wound healing using
nanofibrous scaffolds is an ideal therapeutic option for
the treatment of the burns and defected tissues. The
electrospun nanofibrous scaffolds could be a suitable
substitute for invasive bone transplantation by modifying
their properties with biomolecules and bone morphogenic
proteins like BMP-2.
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